The current studies aimed to investigate further the effects of EB on the Wnt pathway in drug-sensitive and drug-resistant SCLC cells, particularly focusing on GSK3β, apoptosis, and the expression of tumor markers. The gene discussed is GSK3B; the disease is small cell lung carcinoma.